Last Posted: Jan 07, 2019
- Genetic testing does not cause undue worry for breast cancer patients
University of Michigan, January 4, 2019 - 21-gene recurrence score and adjuvant chemotherapy decisions in patients with invasive lobular breast cancer.
Chen Xiang-Hong et al. Biomarkers in medicine 2018 Dec - 21-Gene Recurrence Score Testing in HER2-positive Patients.
Altman Ariella M et al. Clinical breast cancer 2018 Nov - A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
Gagno Sara et al. Clinical breast cancer 2018 Nov - Acceptability of Electronic Visits for Return of Research Results in the Mayo Clinic Biobank.
Olson Janet E et al. Mayo Clinic proceedings. Innovations, quality & outcomes 2018 Dec 2(4) 352-358 - BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2.
Cline Melissa S et al. PLoS genetics 2018 Dec 14(12) e1007752 - Chemoprevention in BRCA1 mutation carriers (CIBRAC): protocol for an open allocation crossover feasibility trial assessing mechanisms of chemoprevention with goserelin and anastrozole versus tamoxifen and acceptability of treatment.
Campbell Aideen M et al. BMJ open 2018 Dec 8(12) e023115 - Gene-expression Profiling - A Decision Impact Analysis: Decision Dependency on Oncotype DX® as a Function of Oncological Work Experience in 117 Cases.
Eichler Christian et al. Anticancer research 2019 Jan 39(1) 297-303 - Next-Generation Sequencing-Based Assessment of JAK2, PD-L1, and PD-L2 Copy Number Alterations at 9p24.1 in Breast Cancer: Potential Implications for Clinical Management.
Gupta Sounak et al. The Journal of molecular diagnostics : JMD 2018 Dec - Sistas Taking a Stand for Breast Cancer Research (STAR) Study: A Community-Based Participatory Genetic Research Study to Enhance Participation and Breast Cancer Equity among African American Women in Memphis, TN.
Smith Alana et al. International journal of environmental research and public health 2018 Dec 15(12)
No hay comentarios:
Publicar un comentario